AI assistant
C&C Group Plc Remuneration Information 2022
6269_def-14a_2022-07-28_b3ce7396-baab-40bb-bf18-3bead36c6c64.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0888U
C&C Group Plc
28 July 2022
C&C Group plc
('C&C')
2021 Long Term Incentive Plan ('LTIP') Awards
On 15 June 2021, LTIP awards were granted to the Company's Executive Directors. The performance conditions for those awards were announced on 28 July 2021, and reported in the Company's Directors' Remuneration Report for the period ended 28 February 2022.
Following a review of the targets for the EPS element of the performance conditions, the Remuneration Committee has noted that the EPS target for maximum vesting had not been adjusted for the impact of the rights issue undertaken by the Company in 2021. Accordingly, the EPS target for maximum vesting has been subsequently adjusted for the rights issue consistent with International accounting standards (IAS 33) as set out below. The Free Cash Flow and Environmental targets have not been adjusted. No other changes have been made to the awards.
| Measure | Weighting | Targets as originally set | Adjusted targets |
| Earnings per share | 45% | Threshold (25% vesting) - 22 cents Maximum - 27 cents By the end of year 3 target range (end of FY24) rather than as a cumulative target. |
Threshold (25% vesting) - 22 cents Maximum - 24.5 cents By the end of year 3 target range (end of FY24) rather than as a cumulative target. |
Contacts
C&C Group plcPatrick McMahon, Chief Financial Officer
Ewan Robertson, Finance and Investor Relations Director
Email: [email protected]
FTI ConsultingJonathan Neilan / Paddy Berkery
Tel: +353 86 231 4135 / +353 86 602 5988
Email: [email protected]
Novella CommunicationsTim Robertson
Tel: +44 203 151 7008
Email: [email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHPPUBWMUPPUBR